Trejdosiewicz L K, Calabrese A, Smart C J, Oakes D J, Howdle P D, Crabtree J E, Losowsky M S, Lancaster F, Boylston A W
Department of Medicine, St James's University Hospital, Leeds, England.
Clin Exp Immunol. 1991 Jun;84(3):440-4.
T cells expressing the gamma delta heterodimer of the T cell receptor (TCR) were studied with respect to their occurrence and expression of gamma delta TCR variable region (V) genes in the normal gastrointestinal mucosa and in a variety of inflammatory conditions. In controls, gamma delta TCR+ cells were a minority population confined to the epithelial compartment of stomach, small bowel and colonic mucosae. Unlike in the periphery, gastro-intestinal gamma delta TCR+ intraepithelial lymphocytes (IEL) were mainly V delta 1+ (89.98 +/- 17.70%); few were V delta 2+ (6.04 +/- 13.8%) or V gamma 9+ (11.38 +/- 10.73%). All gamma delta TCR+ IEL were CD5low; nearly half were CD8+ and the remainder were CD4-CD8- 'double negatives'. There was no significant change from normal in percentages of gamma delta TCR+ IEL in H. pylori-associated gastritis, Crohn's disease and ulcerative colitis. However, in coeliac disease, gamma delta TCR+ IEL were elevated from 2.54% (+/- 1.71) in controls to 29.6% (+/- 16.1) in untreated patients (P less than 0.001) and 18.5% (+/- 7.2) in treated patients (P less than 0.001) and more were CD4-CD8-. Otherwise, gamma delta TCR+ IEL phenotypes were little changed: the majority remained V delta 1+V delta 2-V gamma 9- and all were CD5low. These data suggest that increased gamma delta TCR+ IEL are not a generalized response to intestinal inflammation or to stress proteins, although the typical V delta 1+V delta 2-V gamma 9- CD5low phenotype is retained.
我们研究了表达T细胞受体(TCR)γδ异二聚体的T细胞在正常胃肠道黏膜以及多种炎症状态下的发生情况和γδ TCR可变区(V)基因的表达。在对照组中,γδ TCR+细胞是少数群体,局限于胃、小肠和结肠黏膜的上皮区室。与外周不同,胃肠道γδ TCR+上皮内淋巴细胞(IEL)主要为Vδ1+(89.98±17.70%);少数为Vδ2+(6.04±13.8%)或Vγ9+(11.38±10.73%)。所有γδ TCR+ IEL均为CD5低表达;近一半为CD8+,其余为CD4-CD8-“双阴性”。在幽门螺杆菌相关性胃炎、克罗恩病和溃疡性结肠炎中,γδ TCR+ IEL的百分比与正常情况相比无显著变化。然而,在乳糜泻中,γδ TCR+ IEL在未治疗患者中从对照组的2.54%(±1.71)升高至29.6%(±16.1)(P<0.001),在治疗患者中为18.5%(±7.2)(P<0.001),且更多为CD4-CD8-。此外,γδ TCR+ IEL的表型变化不大:大多数仍为Vδ1+Vδ2-Vγ9-,且均为CD5低表达。这些数据表明,γδ TCR+ IEL增加并非对肠道炎症或应激蛋白的普遍反应,尽管典型的Vδ1+Vδ2-Vγ9- CD5低表达表型得以保留。